SAGE Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing and commercializing medicines to treat central nervous system (CNS) disorders. The Company's lead product candidate, SAGE-547 is an intravenou... Read more
CNBC
MarketWatch
MarketWatch
Yahoo
Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.